These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12720152)

  • 41. p38 mitogen-activated protein kinase mediates tumor necrosis factor-alpha-induced apoptosis in rat fetal brown adipocytes.
    Valladares A; Alvarez AM; Ventura JJ; Roncero C; Benito M; Porras A
    Endocrinology; 2000 Dec; 141(12):4383-95. PubMed ID: 11108246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The thalidomide saga.
    Melchert M; List A
    Int J Biochem Cell Biol; 2007; 39(7-8):1489-99. PubMed ID: 17369076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel biologically based therapies for myeloma.
    Anderson KC
    Cancer J; 2001; 7 Suppl 1():S19-23. PubMed ID: 11504280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of c-jun N-terminal kinase in the induced release of GM-CSF, RANTES and IL-8 from human airway smooth muscle cells.
    Oltmanns U; Issa R; Sukkar MB; John M; Chung KF
    Br J Pharmacol; 2003 Jul; 139(6):1228-34. PubMed ID: 12871843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current and future therapeutic approach for Waldenström's macroglobulinemia.
    Souchet-Cömpain L; Choquet S; Leblond V; Nguyen S
    Immunotherapy; 2014; 6(3):333-48. PubMed ID: 24762077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins.
    Marriott JB; Clarke IA; Czajka A; Dredge K; Childs K; Man HW; Schafer P; Govinda S; Muller GW; Stirling DI; Dalgleish AG
    Cancer Res; 2003 Feb; 63(3):593-9. PubMed ID: 12566301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Asthma therapeutics--SMi conference: 31 April-1 May 2003, London, UK.
    Lunec A
    IDrugs; 2003 Jun; 6(6):555-9. PubMed ID: 12861984
    [No Abstract]   [Full Text] [Related]  

  • 49. Targeting CD40 in Waldenström's macroglobulinemia.
    Lee M; Advani R
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):87-9. PubMed ID: 19362983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
    Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
    Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel therapeutic agents in Waldenström's macroglobulinemia.
    Ghobrial IM; Leleu X; Azab AK; Runnels J; Jia X; Ngo H; Melhem M; Azab F; Sacco A; Quang P; Burwick N; Moreau AS; Husu E; Farag M; Roccaro A
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):84-6. PubMed ID: 19362982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications.
    Mitsiades N; Mitsiades CS; Poulaki V; Chauhan D; Richardson PG; Hideshima T; Munshi NC; Treon SP; Anderson KC
    Blood; 2002 Jun; 99(12):4525-30. PubMed ID: 12036884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells.
    Liu ZY; Ganju RK; Wang JF; Ona MA; Hatch WC; Zheng T; Avraham S; Gill P; Groopman JE
    J Clin Invest; 1997 Apr; 99(7):1798-804. PubMed ID: 9120025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
    J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiogenesis in Waldenström's macroglobulinemia.
    Terpos E; Tasidou A; Kastritis E; Eleftherakis-Papaiakovou E; Gavriatopoulou M; Migkou M; Dimopoulos MA
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):46-9. PubMed ID: 19362971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?
    Bladé J; Montoto S; Rosiñol L; Montserrat E
    Semin Oncol; 2003 Apr; 30(2):329-31. PubMed ID: 12720163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitogen-activated protein kinase phosphatase-1 negatively regulates the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in A549 human lung epithelial cells.
    Turpeinen T; Nieminen R; Moilanen E; Korhonen R
    J Pharmacol Exp Ther; 2010 Apr; 333(1):310-8. PubMed ID: 20089808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunological effects of thalidomide and its chemical and functional analogs.
    Dredge K; Marriott JB; Dalgleish AG
    Crit Rev Immunol; 2002; 22(5-6):425-37. PubMed ID: 12803319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. KF19514, a phosphodiesterase 4 and 1 inhibitor, inhibits TNF-alpha-induced GM-CSF production by a human bronchial epithelial cell line via inhibition of PDE4.
    Sasaki K; Manabe H
    Inflamm Res; 2004 Jan; 53(1):31-7. PubMed ID: 15021978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.